Affymetrix (NASDAQ:AFFX)
Historical Stock Chart
From Oct 2019 to Oct 2024
Affymetrix to Webcast Presentation at the Lehman Brothers Global Healthcare
Conference
SANTA CLARA, Calif., Feb. 25 /PRNewswire-FirstCall/ -- Affymetrix, Inc. today
announced that senior management will provide a company overview at the Lehman
Brothers Seventh Annual Global Healthcare Conference in Miami Beach, FL. A live
transmission of the presentation will take place at 2 PM ET on Wednesday, March
3, 2004. An archived webcast will be available for 30 days.
To access the live webcast or archived presentation, please go to
http://www.affymetrix.com/ and click on the "Investors" link.
About Affymetrix
Affymetrix is a pioneer in creating breakthrough tools that are driving the
genomic revolution. By applying the principles of semiconductor technology to
the life sciences, Affymetrix develops and commercializes systems that enable
scientists to improve the quality of life. The Company's customers include
pharmaceutical, biotechnology, agrichemical, diagnostics, and consumer products
companies, as well as academic, government, and other non-profit research
institutes. Affymetrix offers an expanding portfolio of integrated products and
services, including its integrated GeneChip(R) brand platform to address the
growing markets focused on understanding the relationship between genes and
human health. Additional information on Affymetrix may be found at
http://www.affymetrix.com/.
DATASOURCE: Affymetrix, Inc.
CONTACT: Doug Farrell, Vice President of Investor Relations of
Affymetrix,Inc., +1-408-731-5285
Web site: http://www.affymetrix.com/